Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report

  • Sholeh Ebrahimpour Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Sirous Jafari Department of Infectious Diseases, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Keywords: Prostatitis, Staphylococcus hemolyticus, Teicoplanin


Prostatitis causes up to 25% of male genitourinary complaint. However, due to technical restrictions in sampling, only in 10% of cases pathogens were identified. In this paper, a patient with chronic prostatitis due to Staphylococcus hemolyticus is described. A 48-year-old man was referred with longstanding (approximately for 18 months) complaint of increased genitourinary symptoms and pain in perineum. In evaluation, moderate growth of methicillin-resistant Staphylococcus hemolyticus (MRSH) in post-prostatic massage voided urine and expressed prostatic secretion (EPS) was positive. Culture of urethral urine (urine or voided bladder 1; VB1), midstream urine (VB2) and post-ejaculation urine specimens were negative. Leukocyte count values in EPS and post-prostatic massage voided urine were 14 and 8 per oil immersion field respectively. PCR of urine samples was positive for Ureaplasma urealyticum and confirmed by repeated analysis.Based on the antimicrobial susceptibility results patient was treated with teicoplanin 400 mg intramuscularly every 12 hours for three doses followed by the daily maintenance dose of 400 mg.  In addition, doxycycline 100 mg twice daily was added to cover Ureaplasma urealyticum. Treatment course completed in 6 weeks. Alleviation of patient’s symptoms begun within the first week of treatment and this trend continued until the end of the treatment.


Lipsky BA, Byren I, Hoey CT. Treatment of bacterial prostatitis. Clin Infect Dis 2010;50(12):1641-52.

de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41(4):301-7.

Zhao WP, Li YT, Chen J, et al. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis. Asian J Androl 2012;14(5):715-9.

Yoon BI, Kim S, Han DS, et al. Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 2012;18(4):444-50.

Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med 2006;355(16):1690-8.

Domingue GJ Sr, Hellstrom WJ. Prostatitis. Clin Microbiol Rev 1998;11(4):604-13.

Seo Y, Lee G. Antimicrobial Resistance Pattern in Enterococcus faecalis Strains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis. Korean J Urol 2013;54(7):477-81.

SU Yun-qin LJ-z, LI Ju-xiang, XIE Qing-fang, YIN Geng-sheng. Identification and drug resistance analysis of pathogenic bacteria in 121 patients with chronic bacterial prostatitis. Chin J Pathophysiol 2012;28(5):941-3.

Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev 2014;27(4):870-926.

Choi YS, Kim KS, Choi SW, et al. Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea. Prostate Int 2013;1(3):133-8.

Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy 2003;49(6):269-79.

Baker SD, Horger DC, Keane TE. Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess. Urology 2004;64(4):808-10.

Pierce JR, Saeed Q, Davis WR. Prostatic abscess due to community-acquired methicillin-resistant Staphylococcus aureus. Am J Med Sci 2008;335(2):154-6.

Naboush A, Abou Yassine A, Yasmin M, Mobarakai N. Community- Acquired Methicillin-Resistant Staphylococcus aureus Prostatic Abscess Presenting as Acute Urinary Retention: A Case Report and Review of the Literature. Case Rep Infect Dis 2013;2013:761793.

Gautam M, Gandhi A, Rose F. Methicillin-resistant Staphylococcus aureus: fatal prostatic abscess in an AIDS patient. South Med J 2008;101(4):449.

Abreu D, Arroyo C, Suarez R, et al. Community-acquired methicillin resistant Staphylococcus aureus: a new aetiological agent of prostatic abscess. BMJ Case Rep 2011;2011.

Park SC, Lee JW, Rim JS. Prostatic abscess caused by community-acquired methicillin-resistant Staphylococcus aureus. Int J Urol 2011;18(7):536-8.

Flannery MT, Humphrey D. Case report of a prostatic abscess with a review of the literature. Case Rep Med 2012;2012:430657.

Wang H, Chen ZH, Zhu YY, Wang T, Wu XJ. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP]. Zhonghua Nan Ke Xue 2006;12(6):490-5.

CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.

Karabakan M, Akdemir S, Akdemir AO, Erkmen AE, Kayabas U. A rare case of prostatic brucellosis mimicking prostate cancer. Urol J 2014;11(6):1987-8.

Dobrovol’skaia LI, Gorpinchenko, II. [Benemycin (rifampicin) concentration in the sex gland excretions in chronic prostatitis]. Antibiotiki.1980;25(4):296-9.

How to Cite
Ebrahimpour S, Jafari S. Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report. J Pharm Care. 5(1-2):37-41.
Case Report(s)